logo

For the Inventor, By the Inventor

West Chester, PA, United States of America

Nalin L Subasinghe

USPTO Granted Patents = 12

Average Co-Inventor Count = 6.9

ph-index = 9

Forward Citations = 126(Granted Patents)


Company Filing History:

goldMedal12 out of 76 
 
3-dimensional Pharmaceuticals, Inc.
 patents

Years Active: 1997-2009

Loading Chart...
12 patents (USPTO):Explore Patents
1. 7482376 - Conjugated complement cascade inhibitors (2009-01-27),
2. 7138530 - Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions (2006-11-21),
3. 7109354 - Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions (2006-09-19),
4. 6562840 - Heteroaryl amidines, methylamidines and guanidines, and the use thereof as protease inhibitors (2003-05-13),
5. 6515002 - Compounds and compositions for treating C1s-mediated diseases and conditions (2003-02-04),
6. 6492403 - Methods of treating C1s-mediated diseases and conditions and compositions thereof (2002-12-10),
7. 6403633 - Heteroaryl amidines, methylamidines and guanidines, and use thereof as protease inhibitors (2002-06-11),
8. 6291514 - Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors (2001-09-18),
9. 6127191 - Aminobenzenedicarboxylic acid-based combinatorial libraries (2000-10-03),
10. 5792769 - Guanidino protease inhibitors (1998-08-11),
11. 5741819 - Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa (1998-04-21),
12. 5612369 - Thrombin inhibitors (1997-03-18),

Title: The Innovative Mind of Nalin L. Subasinghe

Introduction

Nalin L. Subasinghe is a prominent inventor based in West Chester, PA, USA, renowned for his impactful contributions to the field of pharmaceuticals. With a remarkable portfolio of 12 patents, Subasinghe has made significant strides in developing innovative therapies aimed at addressing complement-mediated diseases.

Latest Patents

Among his latest inventions are the Conjugated Complement Cascade Inhibitors, which offer a novel method for treating patients with conditions influenced by the complement cascade. This invention is pivotal as it proposes a targeted approach to managing complex health issues. Another key patent focuses on Thiophene Amidine compounds, detailing a method for alleviating symptoms related to acute or chronic disorders mediated by the classical pathway of the complement cascade. This method involves administering compounds that are precisely formulated to provide therapeutic efficacy.

Career Highlights

Nalin L. Subasinghe's career is closely tied to his work at 3-Dimensional Pharmaceuticals, Inc., a company dedicated to pioneering research in drug development. His innovative mindset and expertise in the pharmaceutical sector have established him as a leading figure in the invention of new treatments.

Collaborations

Throughout his career, Subasinghe has collaborated with esteemed colleagues such as Carl R. Illig and M. Jonathan Rudolph. These partnerships exemplify the collaborative spirit that is often vital in scientific research and innovation.

Conclusion

In summary, Nalin L. Subasinghe represents a dynamic force in the field of pharmaceuticals, driven by his dedication to innovation and therapeutic development. His contributions not only enhance the understanding of complement-mediated diseases but also pave the way for new treatment options that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…